I'm LongbridgeAI, I can summarize articles.TScan Therapeutics terminated CFO Jason A. Amello and CMO Chrystal Louis due to strategic reorganization, effective September 2, 2026. Both departures are without cause, entitling them to severance packages including base salary and COBRA premiums. CEO Gavin MacBeath assumed the duties of Principal Financial and Accounting Officer on the same date.
TScan terminated CFO Jason A. Amello and CMO Chrystal Louis as part of a strategic reorganization, and CEO Gavin MacBeath assumed principal financial and accounting officer duties effective September 2, 2026.
| Individual | Jason A. Amello | Chrystal Louis, M.D., MPH | Gavin MacBeath, Ph.D. |
| Role | Chief Financial Officer | Chief Medical Officer | Chief Executive Officer; Principal Financial Officer and Principal Accounting Officer (assumed) |
| Type of Change | Terminated | Terminated | Assumed additional duties |
| Effective Date | September 2, 2026 | September 2, 2026 | September 2, 2026 |
| Reason | Strategic Reorganization; constitutes Termination without Cause under employment agreement | Strategic Reorganization; constitutes Termination without Cause under employment agreement | Strategic Reorganization; to perform principal financial and accounting officer duties |
| Replacement Info | Not disclosed | Not disclosed | N/A |
| Background Details | Departure governed by Amello Employment Agreement dated Jan 29, 2024; subject to release, entitled to 12 months base salary and up to 12 months COBRA premiums | Departure governed by Louis Employment Agreement dated Apr 4, 2024; subject to release, entitled to 12 months base salary, any unpaid target bonus for FY2025, and up to 12 months COBRA premiums | Information regarding Dr. MacBeath is included in the company proxy filed Apr 17, 2026; no related-party or family relationships reported |
| Board/Committee Role Changes | Not disclosed | Not disclosed | Not disclosed |
Original SEC Filing: TScan Therapeutics, Inc. [ TCRX ] - 8-K - Sep. 02, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.